SCHEMBL18104271

SCHEMBL18104271

O=S(=O)(c1ccccc1)c1c2ccccc2c(-c2cc3ccccc3c3c2oc2ccc4ccccc4c23)c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.39
ABCG2 Q9UNQ0 2/20 0.39
PAX8 Q06710 2/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1A2 P05177 1/20 0.39
FYN P06241 1/20 0.39
MAPK3 P27361 1/20 0.39
MAPT P10636 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
KDM4E B2RXH2 2/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18718016 0.88 ABCG2 (0.40) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18718014 0.86 ABCG2 (0.41) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18718015 0.82 AHR (0.36) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18104252 0.82 ABCG2 (0.43) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18104205 0.81 AHR (0.39) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18104245 0.81 ABCG2 (0.44) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18717993 0.80 GPR84 (0.42) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18717995 0.80 ABCG2 (0.48) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18718002 0.78 ABCG2 (0.46) AHRABCG2PAX8CYP1A1CYP1A2
SCHEMBL18718007 0.78 HTR6 (0.40) AHRABCG2PAX8CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10418566-B2 Condensed cyclic compound and organic light-emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-17 US disclosed
US-20160285011-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-09-29 US disclosed
US-20160285011-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160285011-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME CCNA1, CCNT1, CCNE2 AHR 1994/4885ABCG2 2698/4885PAX8 2147/4885
US-10418566-B2 Condensed cyclic compound and organic light-emitting device comprising the same CCNA1, CCNT1, CCNE2 AHR 1994/4885ABCG2 2698/4885PAX8 2147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.